Project Grant R01DE035592
Award Date 7/16/26
Completion Date 4/30/31
Dollars Obligated $519K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- The National Institute of Dental and Craniofacial Research awarded The Trustees of The University of Pennsylvania $522,405 on May 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the role of taste receptor cells in periodontal homeostasis. The research focuses on how solitary chemosensory cells and macrophages in gingival tissue protect against periodontal disease through taste-like signaling pathways. The work addresses the mechanisms by which these...
- The National Institutes of Health National Institute of Dental and Craniofacial Research awarded The Trustees Of The University Of Pennsylvania $521,273 on September 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121). The award funds research into dendritic cell and T cell dysregulation in periodontitis associated with poorly controlled diabetes. The project examines how hyperglycemia reprograms dendritic cells and T cells through epigenetic mechanisms, activating...
- The National Institute of Dental and Craniofacial Research awarded Loma Linda University $358,823 on September 11, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct structural-functional studies of gingipain biogenesis and localization in periodontitis research. The research addresses therapeutic gaps in managing periodontitis, a chronic disease linked to systemic diseases including atherosclerosis, rheumatoid arthritis, cancers, diabetes, and Alzheimer's...
- The National Institute of Dental and Craniofacial Research (NIDCR), a component of the Department of Health and Human Services National Institutes of Health, awarded Loma Linda University $631,170 on July 21, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct structural-functional studies of gingipain biogenesis and localization in the context of periodontitis and Porphyromonas gingivalis pathogenesis. The project will expand understanding of...
- The National Institute of Dental and Craniofacial Research awarded Baylor College of Medicine $453,797 on June 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the structures and functions of natural products in periodontal disease. The funded research centers on a novel biosynthetic gene cluster found in clinical isolates of Porphyromonas gingivalis that appears to encode an antibiotic selective for other P. gingivalis strains and related oral...
- The National Institute of Dental and Craniofacial Research awarded the University of Illinois $320,660 on April 6, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the immunoregulatory role of dendritic cell subsets in periodontal disease. The award funds research examining how three major dendritic cell subsets—myeloid, lymphoid, and plasmacytoid dendritic cells—respond during periodontal disease resolution and interact functionally with periopathic...
- The National Institute of Dental and Craniofacial Research awarded Virginia Commonwealth University $101,828 on December 1, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct functional and structural characterization of phospholipase A2 in Porphyromonas gingivalis, a keystone pathogen of periodontitis. The research delineates the biochemical and structural features of the PG1879 enzyme as a phospholipase A2 and determines its role in the pathophysiology of...
- The National Institute of Dental and Craniofacial Research awarded the University of Pittsburgh $679,631 on February 15, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate treatment for peri-implantitis via local immunomodulation and the microbiome. The project develops microparticle-based drug delivery systems that provide local, sustained delivery of cytokines and chemokines to modulate the host immune response in peri-implantitis, an inflammatory...
- The National Institute of Dental and Craniofacial Research awarded the Regents of the University of Michigan $429,000 on June 5, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to investigate the effects of recurrent periodontitis on hematopoietic stem cell function. The research establishes a chronic periodontitis model to examine long-term effects on hematopoietic stem cells and defines the functional consequences of chronic periodontitis on these cells, accounting...
- The National Institute of Dental and Craniofacial Research awarded the University of Massachusetts Lowell $100,676 on September 30, 2026, under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop a three-dimensional in vitro human periodontal sulcus tissue model capable of reproducing healthy and disease states of gingivitis and periodontitis. The recipient will engineer a sustained tissue culture system that mimics key anatomical features of the gingival sulcus—including...